Delivery Order SPE2DR25D1205-SPE2DR26F0ZD1
Award Date 12/31/25
Potential Completion Date 1/23/26
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $12,536.26 delivery order to AmerisourceBergen Drug Corp for 60 tablets of INLYTA 5 mg, a pharmaceutical product for medical supply fulfillment. This firm fixed-price delivery order, issued on December 4, 2025, with completion scheduled for December 26, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized competitive procurement procedures with no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $11,895.72 by the Defense Logistics Agency on July 22, 2025, for the supply of INLYTA 5 mg tablets in quantities of 60 units. The contract, which carries a firm fixed-price structure with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of INLYTA 1 mg tablets (180 count) with a ceiling value of $12,565.63. This competitively awarded, non-set-aside contract was executed on November 20, 2025, with an ultimate completion date of December 12, 2025, under firm fixed price terms. The award represents a child delivery order issued against...
- The Defense Logistics Agency awarded a $11,895.72 delivery order to AmerisourceBergen Drug Corp for INLYTA 5 mg tablets (60-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of INLYTA 5 mg tablets (60 count) with a ceiling value of $12,536.26. This is a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Inlyta 5 mg tablets (60-count units) valued at $23,791.44. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a competitive award with no set-aside designation. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $11.9K delivery order to AmerisourceBergen Drug Corp for 60 tablets of INLYTA 5 mg, a targeted cancer therapy medication. This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, with completion required by August 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $12,536.26 to AmerisourceBergen Drug Corp for 60 tablets of INLYTA 5 mg, a pharmaceutical product used in cancer treatment. This non-set-aside, firm fixed price delivery order was awarded on November 12, 2025, with an ultimate completion date of December 4, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $23,791.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of INLYTA 5 mg tablets (60 count). The contract, which is non-set-aside and competitively awarded, designates Conshohocken, Pennsylvania as the place of performance and carries an ultimate completion date of October 20, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $11,923.60 to AmerisourceBergen Drug Corp for the supply of INLYTA 1 mg tablets (180-count units). This contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award selection. The delivery order is scheduled for completion by August 15, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INLYTA is a targeted cancer therapy...